To clarify the clinical features of diabetic macroangiopathy in our country and to set up the control critelia for the multiple risk factors.
Conditions
Interventions
None listed
Sponsors
MSDM
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: type 2 diabetes with or without MA,who chan be followed periodically in out patient clinic.
Exclusion criteria
Exclusion criteria: those who can not visit clinic periodically or age above 80. Brain hemorrhage was removed from CVD.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence and clinical features of MA and the relationship between MA and various riskfactors have been followed clinically in multiple facilities. | — |
Secondary
| Measure | Time frame |
|---|---|
| Relationship between MA and microvascular complications has been evaluated. | — |
Countries
Japan
Outcome results
None listed